A Double-Blind Controlled Study to Evaluate the Effects of Yogurt Enriched with Lactococcus lactis 11/19-B1 and Bifidobacterium lactis on Serum Low-Density Lipoprotein Level and Antigen-Specific Interferon-γ Releasing Ability
by
Kyoko Nishiyama 1, Takahiro Kobayashi 1, Yuko Sato 1, Yoshihisa Watanabe 2, Riki Kikuchi 2, Ryoko Kanno 1, Tetsuo Koshizuka 1, Nozomu Miyazaki 1, Ken Ishioka 1 and Tatsuo Suzutani 1,*
Kyoko Nishiyama 1, Takahiro Kobayashi 1, Yuko Sato 1, Yoshihisa Watanabe 2, Riki Kikuchi 2, Ryoko Kanno 1, Tetsuo Koshizuka 1, Nozomu Miyazaki 1, Ken Ishioka 1 and Tatsuo Suzutani 1,*
1
Department of Microbiology, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan
2
Tohoku Kyodo Milk Co., Ltd., Motomiya 969-1104, Japan
*
Author to whom correspondence should be addressed.
Nutrients 2018, 10(11), 1778; https://doi.org/10.3390/nu10111778
Received: 10 October 2018 / Revised: 9 November 2018 / Accepted: 13 November 2018 / Published: 16 November 2018
In order to clarify the effects of the Lactococcus lactis (L. lactis) 11/19-B1 strain, a double-blind controlled study of yogurt fermented with the strain was carried out. For the study, two kinds of yogurt, the control and test yogurt, were prepared; the control yogurt was fermented with Streptococcus thermophiles, Lactobacillus delbrueckii subspecies bulgaricus, and Lactobacillus acidophilus, and the test yogurt was enriched with L. lactis 11/19-B1 and Bifidobacterium lactis (B. lactis) BB-12 strains. Seventy-six volunteers who had not received treatment with pharmaceuticals were randomly divided into two groups with each group ingesting 80 g of either the test or control yogurt every day for 8 weeks. Before and after yogurt intake, fasting blood was taken and blood sugar, blood lipids, and anti-cytomegalovirus cellular immunity were estimated. In the test yogurt group, low-density lipoprotein (LDL) was significantly decreased (159.1 ± 25.7 to 149.3 ± 24.4; p = 0.02), but this effect was not observed in the control yogurt group. When the test yogurt group was divided into two groups based on LDL levels of over or under 120 mg/dL, this effect was only observed in the high LDL group. No LDL-lowering effect of B. lactis BB-12 strain was previously reported; therefore, the hypocholesterolemic effects observed in this study are thought to be caused by the L. lactis 11/19-B1 strain alone or its combination with the B. lactis BB-12 strain.
View Full-Text
▼
Show Figures
Figure 1
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Nishiyama, K.; Kobayashi, T.; Sato, Y.; Watanabe, Y.; Kikuchi, R.; Kanno, R.; Koshizuka, T.; Miyazaki, N.; Ishioka, K.; Suzutani, T. A Double-Blind Controlled Study to Evaluate the Effects of Yogurt Enriched with Lactococcus lactis 11/19-B1 and Bifidobacterium lactis on Serum Low-Density Lipoprotein Level and Antigen-Specific Interferon-γ Releasing Ability. Nutrients 2018, 10, 1778.
Show more citation formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
